C. Rutland, O. Iweala, K. Anders, J. Ko, P. Mital, S. Gupta, A. Mohan
{"title":"不充分控制的严重哮喘患者的止咳使用:对Omalizumab EXTRA试验的事后分析","authors":"C. Rutland, O. Iweala, K. Anders, J. Ko, P. Mital, S. Gupta, A. Mohan","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1234","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antitussive Utilization in Patients with Inadequately Controlled Severe Asthma: A Post-Hoc Analysis of the Omalizumab EXTRA Trial\",\"authors\":\"C. Rutland, O. Iweala, K. Anders, J. Ko, P. Mital, S. Gupta, A. Mohan\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1234\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":262576,\"journal\":{\"name\":\"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS\",\"volume\":\"85 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1234\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}